+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Mesenchymal Stem Cells Market by Application (Autoimmune Disorders, Cardiovascular, Diabetes), Source (Adipose Tissue, Bone Marrow, Dental Pulp), End User, Product Type, Culture Method, Therapy Type - Global Forecast 2025-2030- Product Image
Mesenchymal Stem Cells Market by Application (Autoimmune Disorders, Cardiovascular, Diabetes), Source (Adipose Tissue, Bone Marrow, Dental Pulp), End User, Product Type, Culture Method, Therapy Type - Global Forecast 2025-2030- Product Image
Sale

Mesenchymal Stem Cells Market by Application (Autoimmune Disorders, Cardiovascular, Diabetes), Source (Adipose Tissue, Bone Marrow, Dental Pulp), End User, Product Type, Culture Method, Therapy Type - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 196 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5518254
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The mesenchymal stem cells market is undergoing rapid transformation as scientific advances move cell therapies from experimental stages to clinical and commercial realities. Amid evolving regulations and market dynamics, senior stakeholders are seeking clarity to capitalize on the sector’s complexity and momentum.

Market Snapshot: Mesenchymal Stem Cells Market Growth Overview

The mesenchymal stem cells market grew from USD 3.98 billion in 2024 to USD 4.55 billion in 2025. It is expected to continue expanding at a CAGR of 13.67%, reaching USD 8.60 billion by 2030. This robust trajectory reflects widespread interest in mesenchymal stem cell-based therapeutics, with hospitals, research institutions, and contract organizations driving both development and adoption. Forward-thinking companies are focusing on production scale, supply chain resilience, and differentiated pipeline offerings.

Scope & Segmentation: Comprehensive Landscape of Opportunities

  • Applications: Autoimmune disorders, cardiovascular conditions, diabetes, neurology, orthopedics, regenerative medicine, wound healing.
  • Sources: Adipose tissue, bone marrow, dental pulp, placenta, umbilical cord.
  • End Users: Cell banks and biorepositories, contract research organizations, hospitals and clinics, pharmaceutical and biotech companies, research institutes.
  • Product Types: Instruments and accessories, kits and reagents (including enzymes, dissociation reagents, growth factors, cytokines, media, supplements, surface markers, antibodies), services.
  • Culture Methods: Bioreactor systems (fixed-bed, hollow-fiber, stirred tank), three-dimensional cultures (hydrogels, scaffolds, spheroids), two-dimensional cultures.
  • Therapy Types: Allogeneic, autologous.
  • Regions: Americas (notably United States, Canada, Brazil, Mexico, Argentina); Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, UAE, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, and others); Asia-Pacific (notably China, India, Japan, Australia, South Korea, Singapore, and more).
  • Companies Profiled: Mesoblast Limited, Pluristem Therapeutics Inc., Athersys, Inc., Lonza Group AG, STEMCELL Technologies Inc., Cellular Biomedicine Group, Inc., Cynata Therapeutics Limited, Anterogen Co., Ltd., Vericel Corporation, SanBio Co., Ltd.

Key Takeaways for Decision Makers

  • Cellular therapy innovation is anchored by ongoing advances in bioreactor design, automation, and genome editing, fueling a pipeline of new clinical and commercial offerings.
  • Increasing standardization in product release and potency measurements is enabling more predictable development and accelerating regulatory pathways for new therapies.
  • Allogeneic therapies are gaining strategic priority due to advantages in scalability and turnaround, though autologous approaches maintain value for high-precision, patient-specific cases.
  • Strategic partnerships among biotech firms, academic centers, and contract organizations are consolidating expertise, infrastructure, and market position.
  • Vertical integration and domestic sourcing are emerging as mitigation strategies to shield product pipelines from supply chain and tariff-driven volatility.
  • Regionally, North America leads in funding and streamlined clinical operations, while Asia Pacific is advancing adoption through policy incentives, robust manufacturing, and growing demand.

Tariff Impact: Navigating the 2025 Regulatory Shifts

The 2025 United States tariffs on critical reagents, instruments, and raw materials have presented substantial cost and logistics challenges for mesenchymal stem cell developers. Organizations are responding by reevaluating supplier networks, investing in local production, and forming consortia to share infrastructure and purchasing power. These strategies are bolstering supply chain resilience, even as short-term project timelines and budgets feel the effects of regulatory changes. Academic and contract research sectors are particularly focused on adapting to cost-sensitive constraints while maintaining momentum in development.

Methodology & Data Sources

This report’s findings are grounded in a dual approach: primary research through interviews with industry leaders and specialists, and secondary analysis of regulatory documents, patent filings, scientific literature, and consortium white papers. Data triangulation included feedback from external advisory panels and application of analytical models such as SWOT, PESTLE, and Porter’s Five Forces to ensure actionable, validated insights.

Why This Report Matters

  • Enables C-suite leaders to align investment and R&D with the latest regulatory, technological, and therapeutic developments across all major regions.
  • Offers deep segmentation and competitive analysis, empowering strategic decisions in sourcing, partnerships, and operational efficiency.
  • Equips market participants to anticipate and counteract risks arising from trade regulations, supply chain shifts, and evolving reimbursement dynamics.

Conclusion

As mesenchymal stem cell therapies mature, decision-makers equipped with robust market intelligence will be best positioned to capture value and steer innovation. This report guides strategic navigation in a sector shaped by both scientific advances and operational complexities.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expansion of allogeneic mesenchymal stem cell therapies targeting osteoarthritis and cartilage repair
5.2. Rising investments in mesenchymal stem cell exosome development for regenerative medicine applications
5.3. Advancements in scalable bioreactor manufacturing processes for clinical grade MSC production
5.4. Regulatory approvals and pathway optimizations accelerating MSC-based immunomodulatory treatments
5.5. Integration of 3D bioprinting with MSCs for personalized tissue engineering constructs
5.6. Emergence of cell banking services offering standardized mesenchymal stem cell therapies globally
5.7. Increasing partnerships between biotech firms and academic institutions for MSC translational research
5.8. Growing focus on genetic engineering of MSCs to enhance homing and therapeutic efficacy
5.9. Adoption of automated closed-system platforms to reduce contamination risks in MSC manufacturing
5.10. Expanding pipeline of MSC therapies undergoing phase III trials for chronic inflammatory diseases
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Mesenchymal Stem Cells Market, by Application
8.1. Introduction
8.2. Autoimmune Disorders
8.3. Cardiovascular
8.4. Diabetes
8.5. Neurology
8.6. Orthopedics
8.7. Regenerative Medicine
8.8. Wound Healing
9. Mesenchymal Stem Cells Market, by Source
9.1. Introduction
9.2. Adipose Tissue
9.3. Bone Marrow
9.4. Dental Pulp
9.5. Placenta
9.6. Umbilical Cord
10. Mesenchymal Stem Cells Market, by End User
10.1. Introduction
10.2. Cell Banks & Biorepositories
10.3. Contract Research Organizations
10.4. Hospitals & Clinics
10.5. Pharmaceutical & Biotech Companies
10.6. Research Institutes
11. Mesenchymal Stem Cells Market, by Product Type
11.1. Introduction
11.2. Instruments & Accessories
11.3. Kits & Reagents
11.3.1. Enzymes & Dissociation Reagents
11.3.2. Growth Factors & Cytokines
11.3.3. Media & Supplements
11.3.4. Surface Markers & Antibodies
11.4. Services
12. Mesenchymal Stem Cells Market, by Culture Method
12.1. Introduction
12.2. Bioreactor Systems
12.2.1. Fixed-Bed
12.2.2. Hollow-Fiber
12.2.3. Stirred Tank
12.3. Three-Dimensional Culture
12.3.1. Hydrogels
12.3.2. Scaffolds
12.3.3. Spheroids
12.4. Two-Dimensional Culture
13. Mesenchymal Stem Cells Market, by Therapy Type
13.1. Introduction
13.2. Allogeneic
13.3. Autologous
14. Americas Mesenchymal Stem Cells Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Mesenchymal Stem Cells Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Mesenchymal Stem Cells Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Mesoblast Limited
17.3.2. Pluristem Therapeutics Inc.
17.3.3. Athersys, Inc.
17.3.4. Lonza Group AG
17.3.5. STEMCELL Technologies Inc.
17.3.6. Cellular Biomedicine Group, Inc.
17.3.7. Cynata Therapeutics Limited
17.3.8. Anterogen Co., Ltd.
17.3.9. Vericel Corporation
17.3.10. SanBio Co., Ltd.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. MESENCHYMAL STEM CELLS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2024 VS 2030 (%)
FIGURE 14. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY THERAPY TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY THERAPY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. MESENCHYMAL STEM CELLS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. MESENCHYMAL STEM CELLS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. MESENCHYMAL STEM CELLS MARKET: RESEARCHAI
FIGURE 28. MESENCHYMAL STEM CELLS MARKET: RESEARCHSTATISTICS
FIGURE 29. MESENCHYMAL STEM CELLS MARKET: RESEARCHCONTACTS
FIGURE 30. MESENCHYMAL STEM CELLS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. MESENCHYMAL STEM CELLS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY DIABETES, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY DIABETES, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY WOUND HEALING, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY WOUND HEALING, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY ADIPOSE TISSUE, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY ADIPOSE TISSUE, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY BONE MARROW, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY BONE MARROW, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY DENTAL PULP, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY DENTAL PULP, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY PLACENTA, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY PLACENTA, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY UMBILICAL CORD, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY UMBILICAL CORD, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY CELL BANKS & BIOREPOSITORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY CELL BANKS & BIOREPOSITORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY INSTRUMENTS & ACCESSORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY INSTRUMENTS & ACCESSORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY ENZYMES & DISSOCIATION REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY ENZYMES & DISSOCIATION REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY GROWTH FACTORS & CYTOKINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY GROWTH FACTORS & CYTOKINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY MEDIA & SUPPLEMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY MEDIA & SUPPLEMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY SURFACE MARKERS & ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY SURFACE MARKERS & ANTIBODIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY KITS & REAGENTS, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY KITS & REAGENTS, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY BIOREACTOR SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY BIOREACTOR SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY FIXED-BED, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY FIXED-BED, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY HOLLOW-FIBER, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY HOLLOW-FIBER, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY STIRRED TANK, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY STIRRED TANK, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY BIOREACTOR SYSTEMS, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY BIOREACTOR SYSTEMS, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY THREE-DIMENSIONAL CULTURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY THREE-DIMENSIONAL CULTURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY HYDROGELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY HYDROGELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY SCAFFOLDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY SCAFFOLDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY SPHEROIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY SPHEROIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY THREE-DIMENSIONAL CULTURE, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY THREE-DIMENSIONAL CULTURE, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY TWO-DIMENSIONAL CULTURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY TWO-DIMENSIONAL CULTURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY ALLOGENEIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY ALLOGENEIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY KITS & REAGENTS, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY KITS & REAGENTS, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY BIOREACTOR SYSTEMS, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY BIOREACTOR SYSTEMS, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY THREE-DIMENSIONAL CULTURE, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY THREE-DIMENSIONAL CULTURE, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY KITS & REAGENTS, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY KITS & REAGENTS, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY BIOREACTOR SYSTEMS, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY BIOREACTOR SYSTEMS, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY THREE-DIMENSIONAL CULTURE, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY THREE-DIMENSIONAL CULTURE, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 137. CANADA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 138. CANADA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 139. CANADA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 140. CANADA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 141. CANADA MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 142. CANADA MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 143. CANADA MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 144. CANADA MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 145. CANADA MESENCHYMAL STEM CELLS MARKET SIZE, BY KITS & REAGENTS, 2018-2024 (USD MILLION)
TABLE 146. CANADA MESENCHYMAL STEM CELLS MARKET SIZE, BY KITS & REAGENTS, 2025-2030 (USD MILLION)
TABLE 147. CANADA MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2018-2024 (USD MILLION)
TABLE 148. CANADA MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2025-2030 (USD MILLION)
TABLE 149. CANADA MESENCHYMAL STEM CELLS MARKET SIZE, BY BIOREACTOR SYSTEMS, 2018-2024 (USD MILLION)
TABLE 150. CANADA MESENCHYMAL STEM CELLS MARKET SIZE, BY BIOREACTOR SYSTEMS, 2025-2030 (USD MILLION)
TABLE 151. CANADA MESENCHYMAL STEM CELLS MARKET SIZE, BY THREE-DIMENSIONAL CULTURE, 2018-2024 (USD MILLION)
TABLE 152. CANADA MESENCHYMAL STEM CELLS MARKET SIZE, BY THREE-DIMENSIONAL CULTURE, 2025-2030 (USD MILLION)
TABLE 153. CANADA MESENCHYMAL STEM CELLS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 154. CANADA MESENCHYMAL STEM CELLS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 155. MEXICO MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 156. MEXICO MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 157. MEXICO MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 158. MEXICO MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 159. MEXICO MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 160. MEXICO MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 161. MEXICO MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 162. MEXICO MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 163. MEXICO MESENCHYMAL STEM CELLS MARKET SIZE, BY KITS & REAGENTS, 2018-2024 (USD MILLION)
TABLE 164. MEXICO MESENCHYMAL STEM CELLS MARKET SIZE, BY KITS & REAGENTS, 2025-2030 (USD MILLION)
TABLE 165. MEXICO MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2018-2024 (USD MILLION)
TABLE 166. MEXICO MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2025-2030 (USD MILLION)
TABLE 167. MEXICO MESENCHYMAL STEM CELLS MARKET SIZE, BY BIOREACTOR SYSTEMS, 2018-2024 (USD MILLION)
TABLE 168. MEXICO MESENCHYMAL STEM CELLS MARKET SIZE, BY BIOREACTOR SYSTEMS, 2025-2030 (USD MILLION)
TABLE 169. MEXICO MESENCHYMAL STEM CELLS MARKET SIZE, BY THREE-DIMENSIONAL CULTURE, 2018-2024 (USD MILLION)
TABLE 170. MEXICO MESENCHYMAL STEM CELLS MARKET SIZE, BY THREE-DIMENSIONAL CULTURE, 2025-2030 (USD MILLION)
TABLE 171. MEXICO MESENCHYMAL STEM CELLS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 172. MEXICO MESENCHYMAL STEM CELLS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL MESENCHYMAL STEM CELLS MARKET SIZE, BY KITS & REAGENTS, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL MESENCHYMAL STEM CELLS MARKET SIZE, BY KITS & REAGENTS, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL MESENCHYMAL STEM CELLS MARKET SIZE, BY BIOREACTOR SYSTEMS, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL MESENCHYMAL STEM CELLS MARKET SIZE, BY BIOREACTOR SYSTEMS, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL MESENCHYMAL STEM CELLS MARKET SIZE, BY THREE-DIMENSIONAL CULTURE, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL MESENCHYMAL STEM CELLS MARKET SIZE, BY THREE-DIMENSIONAL CULTURE, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL MESENCHYMAL STEM CELLS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL MESENCHYMAL STEM CELLS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA MESENCHYMAL STEM CELLS MARKET SIZE, BY KITS & REAGENTS, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA MESENCHYMAL STEM CELLS MARKET SIZE, BY KITS & REAGENTS, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA MESENCHYMAL STEM CELLS MARKET SIZE, BY BIOREACTOR SYSTEMS, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA MESENCHYMAL STEM CELLS MARKET SIZE, BY BIOREACTOR SYSTEMS, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA MESENCHYMAL STEM CELLS MARKET SIZE, BY THREE-DIMENSIONAL CULTURE, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA MESENCHYMAL STEM CELLS MARKET SIZE, BY THREE-DIMENSIONAL CULTURE, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA MESENCHYMAL STEM CELLS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA MESENCHYMAL STEM CELLS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY KITS & REAGENTS, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY KITS & REAGENTS, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY BIOREACTOR SYSTEMS, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY BIOREACTOR SYSTEMS, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY THREE-DIMENSIONAL CULTURE, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY THREE-DIMENSIONAL CULTURE, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 230. UNITED KINGDOM MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 232. UNITED KINGDOM MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM MESENCHYMAL STEM CELLS MARKET SIZE, BY KITS & REAGENTS, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM MESENCHYMAL STEM CELLS MARKET SIZE, BY KITS & REAGENTS, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM MESENCHYMAL STEM CELLS MARKET SIZE, BY BIOREACTOR SYSTEMS, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM MESENCHYMAL STEM CELLS MARKET SIZE, BY BIOREACTOR SYSTEMS, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM MESENCHYMAL STEM CELLS MARKET SIZE, BY THREE-DIMENSIONAL CULTURE, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM MESENCHYMAL STEM CELLS MARKET SIZE, BY THREE-DIMENSIONAL CULTURE, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM MESENCHYMAL STEM CELLS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM MESENCHYMAL STEM CELLS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 247. GERMANY MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 248. GERMANY MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 249. GERMANY MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 250. GERMANY MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 251. GERMANY MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 252. GERMANY MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 253. GERMANY MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 254. GERMANY MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 255. GERMANY MESENCHYMAL STEM CELLS MARKET SIZE, BY KITS & REAGENTS, 2018-2024 (USD MILLION)
TABLE 256. GERMANY MESENCHYMAL STEM CELLS MARKET SIZE, BY KITS & REAGENTS, 2025-2030 (USD MILLION)
TABLE 257. GERMANY MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2018-2024 (USD MILLION)
TABLE 258. GERMANY MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2025-2030 (USD MILLION)
TABLE 259. GERMANY MESENCHYMAL STEM CELLS MARKET SIZE, BY BIOREACTOR SYSTEMS, 2018-2024 (USD MILLION)
TABLE 260. GERMANY MESENCHYMAL STEM CELLS MARKET SIZE, BY BIOREACTOR SYSTEMS, 2025-2030 (USD MILLION)
TABLE 261. GERMANY MESENCHYMAL STEM CELLS MARKET SIZE, BY THREE-DIMENSIONAL CULTURE, 2018-2024 (USD MILLION)
TABLE 262. GERMANY MESENCHYMAL STEM CELLS MARKET SIZE, BY THREE-DIMENSIONAL CULTURE, 2025-2030 (USD MILLION)
TABLE 263. GERMANY MESENCHYMAL STEM CELLS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 264. GERMANY MESENCHYMAL STEM CELLS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 265. FRANCE MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 266. FRANCE MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 267. FRANCE MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 268. FRANCE MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 269. FRANCE MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 270. FRANCE MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 271. FRANCE MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 272. FRANCE MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 273. FRANCE MESENCHYMAL STEM CELLS MARKET SIZE, BY KITS & REAGENTS, 2018-2024 (USD MILLION)
TABLE 274. FRANCE MESENCHYMAL STEM CELLS MARKET SIZE, BY KITS & REAGENTS, 2025-2030 (USD MILLION)
TABLE 275. FRANCE MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2018-2024 (USD MILLION)
TABLE 276. FRANCE MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2025-2030 (USD MILLION)
TABLE 277. FRANCE MESENCHYMAL STEM CELLS MARKET SIZE, BY BIOREACTOR SYSTEMS, 2018-2024 (USD MILLION)
TABLE 278. FRANCE MESENCHYMAL STEM CELLS MARKET SIZE, BY BIOREACTOR SYSTEMS, 2025-2030 (USD MILLION)
TABLE 279. FRANCE MESENCHYMAL STEM CELLS MARKET SIZE, BY THREE-DIMENSIONAL CULTURE, 2018-2024 (USD MILLION)
TABLE 280. FRANCE MESENCHYMAL STEM CELLS MARKET SIZE, BY THREE-DIMENSIONAL CULTURE, 2025-2030 (USD MILLION)
TABLE 281. FRANCE MESENCHYMAL STEM CELLS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 282. FRANCE MESENCHYMAL STEM CELLS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 283. RUSSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 284. RUSSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 285. RUSSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 286. RUSSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 287. RUSSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 288. RUSSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 289. RUSSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 290. RUSSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 291. RUSSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY KITS & REAGENTS, 2018-2024 (USD MILLION)
TABLE 292. RUSSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY KITS & REAGENTS, 2025-2030 (USD MILLION)
TABLE 293. RUSSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2018-2024 (USD MILLION)
TABLE 294. RUSSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2025-2030 (USD MILLION)
TABLE 295. RUSSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY BIOREACTOR SYSTEMS, 2018-2024 (USD MILLION)
TABLE 296. RUSSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY BIOREACTOR SYSTEMS, 2025-2030 (USD MILLION)
TABLE 297. RUSSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY THREE-DIMENSIONAL CULTURE, 2018-2024 (USD MILLION)
TABLE 298. RUSSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY THREE-DIMENSIONAL CULTURE, 2025-2030 (USD MILLION)
TABLE 299. RUSSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 300. RUSSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 301. ITALY MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 302. ITALY MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 303. ITALY MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 304. ITALY MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 305. ITALY MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 306. ITALY MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 307. ITALY MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 308. ITALY MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 309. ITALY MESENCHYMAL STEM CELLS MARKET SIZE, BY KITS & REAGENTS, 2018-2024 (USD MILLION)
TABLE 310. ITALY MESENCHYMAL STEM CELLS MARKET SIZE, BY KITS & REAGENTS, 2025-2030 (USD MILLION)
TABLE 311. ITALY MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2018-2024 (USD MILLION)
TABLE 312. ITALY MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2025-2030 (USD MILLION)
TABLE 313. ITALY MESENCHYMAL STEM CELLS MARKET SIZE, BY BIOREACTOR SYSTEMS, 2018-2024 (USD MILLION)
TABLE 314. ITALY MESENCHYMAL STEM CELLS MARKET SIZE, BY BIOREACTOR SYSTEMS, 2025-2030 (USD MILLION)
TABLE 315. ITALY MESENCHYMAL STEM CELLS MARKET SIZE, BY THREE-DIMENSIONAL CULTURE, 2018-2024 (USD MILLION)
TABLE 316. ITALY MESENCHYMAL STEM CELLS MARKET SIZE, BY THREE-DIMENSIONAL CULTURE, 2025-2030 (USD MILLION)
TABLE 317. ITALY MESENCHYMAL STEM CELLS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 318. ITALY MESENCHYMAL STEM CELLS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 319. SPAIN MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 320. SPAIN MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 321. SPAIN MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 322. SPAIN MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 323. SPAIN MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 324. SPAIN MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 325. SPAIN MESENCHYMA

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Mesenchymal Stem Cells market report include:
  • Mesoblast Limited
  • Pluristem Therapeutics Inc.
  • Athersys, Inc.
  • Lonza Group AG
  • STEMCELL Technologies Inc.
  • Cellular Biomedicine Group, Inc.
  • Cynata Therapeutics Limited
  • Anterogen Co., Ltd.
  • Vericel Corporation
  • SanBio Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages196
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 4.55 Billion
Forecasted Market Value ( USD ) by 2030 $ 8.6 Billion
Compound Annual Growth Rate13.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Mesenchymal Stem Cell Therapy Market Size, Share & Trends Analysis Report by Type (Autologous, Allogenic), Source (Bone Marrow, Umbilical Cord, Adipose), Disease Indication, Region, with Growth Forecasts, 2025-2030 - Product Image

Mesenchymal Stem Cell Therapy Market Size, Share & Trends Analysis Report by Type (Autologous, Allogenic), Source (Bone Marrow, Umbilical Cord, Adipose), Disease Indication, Region, with Growth Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From
Mesenchymal Stem Cells Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Mesenchymal Stem Cells Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 182 Pages
  • Global
From
Mesenchymal Stem Cells Market Report 2025 - Product Image

Mesenchymal Stem Cells Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Mesenchymal Stem Cell Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Mesenchymal Stem Cell Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 94 Pages
  • Global
From
Mesenchymal Stem Cells (MSC) - Global Strategic Business Report - Product Image

Mesenchymal Stem Cells (MSC) - Global Strategic Business Report

  • Report
  • 202 Pages
  • Global
From

About the Mesenchymal Stem Cell Market

The Mesenchymal Stem Cell (MSC) market is a rapidly growing sector of the genomics industry. MSCs are multipotent cells that can differentiate into a variety of cell types, including bone, cartilage, and fat. They are used in regenerative medicine, tissue engineering, and drug discovery. MSCs are also being studied for their potential to treat a variety of diseases, including cancer, autoimmune disorders, and cardiovascular diseases. The MSC market is driven by advances in genomics technology, such as gene editing and sequencing, which have enabled researchers to better understand the biology of MSCs and develop new therapeutic applications. Additionally, the increasing demand for personalized medicine and the growing awareness of the potential of MSCs to treat a variety of diseases are driving the growth of the MSC market. Some of the major companies in the MSC market include Thermo Fisher Scientific, Merck KGaA, Lonza Group, STEMCELL Technologies, and Cellular Dynamics International. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.